A real-world, retrospective, observational study of Abiraterone acetate plus prednisone for the treatment of metastatic castration resistant prostate cancer
Latest Information Update: 09 May 2019
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone (Primary) ; Corticosteroid
- Indications Prostate cancer
- Focus Therapeutic Use
- 09 May 2019 New trial record